Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.

Suppr

超能文献

作者信息

Levenbook Inessa, Draper Ken

出版信息

J Virol. 2009 May;83(10):5289-90; author reply 5290-2. doi: 10.1128/JVI.02621-08.

DOI:10.1128/JVI.02621-08

PMID:19383635

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2682093/

Abstract

摘要

相似文献

Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.

J Virol. 2009 May;83(10):5289-90; author reply 5290-2. doi: 10.1128/JVI.02621-08.

[A live vaccine against tick-borne encephalitis: the principles of selecting the vaccinal strains].

Zh Mikrobiol Epidemiol Immunobiol. 1993 May-Jun(3):70-6.

Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.

mBio. 2019 Apr 23;10(2):e02904-18. doi: 10.1128/mBio.02904-18.

[Characteristics of neurovirulence, stability, and immunogenicity of attenuated variants of TP-21 Langat virus].

Vopr Virusol. 1994 Sep-Oct;39(5):220-3.

[Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].

Vopr Virusol. 1982 Jul-Aug;27(4):461-4.

Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.

J Med Virol. 2009 Oct;81(10):1777-85. doi: 10.1002/jmv.21587.

Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.

Vaccine. 2006 Jan 12;24(2):133-43. doi: 10.1016/j.vaccine.2005.07.067. Epub 2005 Aug 9.

The role of non-human primates in the neurological safety of live viral vaccines (review).

Biologicals. 2011 Jan;39(1):1-8. doi: 10.1016/j.biologicals.2010.11.003. Epub 2010 Dec 22.

[Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis].

Zh Mikrobiol Epidemiol Immunobiol. 1985 Jun(6):34-9.

[Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis].

Vopr Virusol. 1983 Sep-Oct;28(5):622-6.

引用本文的文献

High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence.

Vaccine. 2010 Dec 6;28(52):8315-26. doi: 10.1016/j.vaccine.2010.07.070. Epub 2010 Aug 3.

Cellular inflammatory response to flaviviruses in the central nervous system of a primate host.

J Histochem Cytochem. 2009 Oct;57(10):973-89. doi: 10.1369/jhc.2009.954180. Epub 2009 Jul 6.

本文引用的文献

Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates.

J Virol. 2008 Jun;82(11):5255-68. doi: 10.1128/JVI.00172-08. Epub 2008 Mar 19.

Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.

Trans R Soc Trop Med Hyg. 2007 Mar;101(3):289-98. doi: 10.1016/j.trstmh.2006.08.006. Epub 2006 Dec 12.

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.

Virology. 2007 Mar 30;360(1):36-49. doi: 10.1016/j.virol.2006.10.026. Epub 2006 Nov 13.

Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.

Vaccine. 2006 Sep 29;24(40-41):6392-404. doi: 10.1016/j.vaccine.2006.06.008. Epub 2006 Jun 21.

Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos.

Biologicals. 2006 Sep;34(3):191-7. doi: 10.1016/j.biologicals.2005.09.005. Epub 2005 Dec 2.

IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31-February 1, 2005, Geneva.

Biologicals. 2006 Sep;34(3):233-6. doi: 10.1016/j.biologicals.2005.08.005. Epub 2005 Oct 28.

Yellow fever vaccine.

Expert Rev Vaccines. 2005 Aug;4(4):553-74. doi: 10.1586/14760584.4.4.553.

Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.

Vaccine. 2006 Jan 12;24(2):133-43. doi: 10.1016/j.vaccine.2005.07.067. Epub 2005 Aug 9.

Viral encephalitis: a review of diagnostic methods and guidelines for management.

Eur J Neurol. 2005 May;12(5):331-43. doi: 10.1111/j.1468-1331.2005.01126.x.

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

J Virol. 2004 Sep;78(18):9998-10008. doi: 10.1128/JVI.78.18.9998-10008.2004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验